Apr 26, 2013
Freedom will become a wholly owned subsidiary of the Fagron Group, a global market leader in pharmaceutical compounding.
TULSA, Oklahoma – April 25, 2013 – Freedom Pharmaceuticals, Inc. announced today that they have been acquired by Arseus, the holding company for Fagron, a global leader in pharmaceutical
compounding. Freedom will immediately become a wholly owned subsidiary of Fagron.
Freedom Pharmaceuticals, a privately held company located in Tulsa, Okla., specializes in the custom wholesale distribution of fine compounding chemicals – active pharmaceutical ingredients (APIs) and excipients – to independent compounding pharmacies throughout the United States.
“I am looking forward to combining forces with the Fagron Group. Fagron’s global and rapidly expanding network offers great potential to roll out successful and unique products and concepts internationally,” Jacob (Jake) Jackson, President of Freedom Pharmaceuticals, said. “Our clients will benefit from an excellent range of more than 1,500 high quality products and services, and our employees will enjoy opportunities for further development in an international environment. Further, I look forward to the opportunity of serving as President of Fagron North America and contributing to the future growth and expansion of both Freedom Pharmaceuticals and the Fagron Group.”
Jackson will continue to serve as President and CEO of Freedom Pharmaceuticals and will assume the position of President of Fagron North America in January 2014.
|Jun 03, 2019||PrimeCare® Integrates MedTek21® to Offer Facility-based Genomic Testing|
|May 22, 2019||Letco Med Announces the Launch of a New Industry-Leading Website and E-Commerce ...|
|May 17, 2019||MEDISCA Granted Planetary Mixing Patent and Exclusive Distribution Agreement|
|May 02, 2019||Transaction Data Systems (TDS) Delivers Smarter Approach to Claim Reconciliation|
|Apr 22, 2019||Visante healthcare consulting firm announces Judi Jacobi, PharmD, to join consul...|
|Apr 17, 2019||As an aging population demands more efficient pharmacy solutions, the founder of...|
|Apr 17, 2019||Adam Wallace Named Chief Technology Officer at Transaction Data Systems (TDS)|
|Apr 15, 2019||PharmaLink to Exhibit at 2019 Asembia Specialty Pharmacy Summit|
|Apr 04, 2019||Transaction Data Systems (TDS) Announces Acquisition of Pharm Assess, Inc.|
|Apr 01, 2019||Chad Collins Named President of Akro-Mils and Jamco Products|
|Mar 22, 2019||Tutela Welcomes Octapharma Plasma|
|Mar 18, 2019||Verity Solutions Recognized as Category Leader for 340B Management Systems in 20...|
|Mar 07, 2019||Stormont Vail Health Partners with Omnicell to Enhance Medication Management Str...|
|Mar 06, 2019||Rebranding Focuses ALG Mission - Combining Our Best to Bring You Our Best|
|Mar 04, 2019||RXinsider Celebrates 20 Years, 1999 - 2019|
|Feb 28, 2019||Lupin launches Generic Ranolazine ER Tablets in U.S.|
|Feb 18, 2019||QS/1® Offers Compliance Packaging Label Solution|
|Feb 15, 2019||QS/1 Partnership Offers Compliant Patient Communications|
|Feb 14, 2019||RXinsider is Proud to Welcome our Newest Partners!|
|Feb 12, 2019||Albertsons Companies Pharmacies Adopt TemperPack's ClimaCell™ Packaging|
|Feb 07, 2019||Fagron Launches New Brand Identity and Purpose|
|Feb 07, 2019||Medicine-On-Time has come together with Clinical Support Services, a leader in M...|
|Feb 04, 2019||Letco Med and Ananda Professional Partner to Bring CBD and Education to Compound...|
|Jan 30, 2019||Texas Children’s Hospital Expands Partnership with Omnicell|
|Jan 16, 2019||Helmer Scientific Launches the First Professional Medical-grade Refrigerators|
|Jan 15, 2019||The Compliance Team™ celebrates 25 years of accreditation transformation|
|Jan 11, 2019||CORE Higher Education Group partners with Pharmacists Mutual|
|Jan 10, 2019||SCA Pharma Awarded National Outsourced I.V. Admixture Services Agreement with Pr...|
|Jan 08, 2019||Tutela Welcomes the Center for Organ Recovery and Education|
|Dec 13, 2018||PharmaLink Launches Updated Website|
Connect with thousands of pharmacy professionals throughout every practice setting.